Vaccine | Two stage cluster (30 × 30) | Systematic sampling | |||
Coverage estimate | 95% CI | Coverage estimate | 95% CI | ||
BCG | 0.99 | (0.98, 0.99) | 0.99 | (0.98, 0.99) | |
OPV | OPV1 | 0.99 | (0.98, 0.99) | 0.99 | (0.98,0.99) |
OPV2 | 0.98 | (0.97, 0.98) | 0.99 | (0.98,0.99) | |
OPV3 | 0.98 | (0.97, 0.98) | 0.99 | (0.98,0.99) | |
OPV4 | 0.97 | (0.96, 0.97) | 0.99 | (0.98,0.99) | |
OPV5 | 0.90 | (0.89, 0.90) | 0.89 | (0.86,0.91) | |
OPV6 | 0.54 | (0.53, 0.54) | 0.54 | (0.50,0.57) | |
DPT | DPT1 | 0.98 | (0.97, 0.98) | 0.99 | (0.98,0.99) |
DPT2 | 0.98 | (0.97, 0.98) | 0.99 | (0.98,0.99) | |
DPT3 | 0.97 | (0.96, 0.97) | 0.98 | (0.98,0.99) | |
DPT4 | 0.90 | (0.89, 0.90) | 0.90 | (0.88,0.91) | |
DPT5 | 0.52 | (0.51, 0.52) | 0.51 | (0.47,0.54) | |
Hepatitis B | HepB1 | 0.58 | (0.57, 0.58) | 0.56 | (0.52,0.59) |
HepB2 | 0.59 | (0.58, 0.59) | 0.56 | (0.52,0.59) | |
Hib | Hib1 | 0.57 | (0.56, 0.57) | 0.55 | (0.51,0.58) |
Hib2 | 0.57 | (0.56, 0.57) | 0.55 | (0.51,0.58) | |
Hib3 | 0.57 | (0.50, 0.64) | 0.55 | (0.51,0.58) | |
Measles | 0.64 | (0.63, 0.64) | 0.64 | (0.60, 0.67) | |
MMR | 0.52 | (0.51, 0.52) | 0.50 | (0.46, 0.53) |